EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Dynamic Modulation of IRE1α-XBP1 Signaling by Adenovirus

Yumi Jang iD, Fred Bunz iD

Pathogens · 2025

DOI: 10.3390/pathogens14020132 ↗

At a glance

Journal article in Pathogens, 2025. Written by Yumi Jang and 1 co-authors. Institution: Department of Radiation Oncology and Molecular Radiation Sciences, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of …. Major MEDLINE topics: Endoribonucleases, Protein Serine-Threonine Kinases, X-Box Binding Protein 1, Signal Transduction. Cited 2 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, Foundation for the NIH, NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The abundant production of foreign proteins and nucleic acids during viral infection elicits a variety of stress responses in host cells. Viral proteins that accumulate in the endoplasmic reticulum (ER) can trigger the unfolded protein response (UPR), a coordinated signaling program that culminates in the expression of downstream genes that collectively restore protein homeostasis. The model pathogen adenovirus serotype 5 (HAdV5) activates the UPR via the signaling axis formed by inositol-requiring enzyme type 1 (IRE1α) and the X-box binding protein 1 (XBP1), a transcription factor required for immune function. Recent studies have suggested that IRE1α-XBP1 activity supports adenovirus replication. Here, we show that HAdV5 exerted opposing effects on IRE1α and XBP1. IRE1α was activated in response to HAdV5, but the production of the XBP1 isoform, XBP1s, was post-transcriptionally blocked. The tumor suppressor p53, which is eliminated by HAdV5 after infection, inhibited IRE1α activation. The de-repression of IRE1α following the degradation of p53 conceivably reflects a novel antiviral mechanism, which HAdV5 ultimately evades by co-opting IRE1α and suppressing XBP1s. Our findings illustrate the opposing mechanisms used by adenoviruses and their host cells to exert control over the UPR, a critical determinant of cell fate.

Subjects

MeSH terms (MEDLINE)

EndoribonucleasesProtein Serine-Threonine KinasesX-Box Binding Protein 1Signal TransductionAdenoviruses, HumanHost-Pathogen InteractionsAdenoviridaeHumansUnfolded Protein ResponseTumor Suppressor Protein p53Adenoviridae InfectionsVirus Replication

Author keywords

XBP1 splicingadenovirusp53unfolded protein response

Substances

EndoribonucleasesProtein Serine-Threonine KinasesX-Box Binding Protein 1ERN1 protein, humanXBP1 protein, humanTumor Suppressor Protein p53

Authors and institutions

  • Department of Radiation Oncology and Molecular Radiation Sciences, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Department of Food Science and Nutrition, College of Human Ecology, University of Ulsan, Ulsan 44610, Republic of Korea.

ORCID profiles: Yumi Jang, Fred Bunz

Funding

  • NIGMS NIH HHS
  • Foundation for the NIH
  • NIH HHS
  • National Institute of General Medical Sciences, National Institutes of Health

Cite

APA

Jang, Y., & Bunz, F. (2025). Dynamic Modulation of IRE1α-XBP1 Signaling by Adenovirus. Pathogens. https://doi.org/10.3390/pathogens14020132

Vancouver

Jang Y, Bunz F. Dynamic Modulation of IRE1α-XBP1 Signaling by Adenovirus. Pathogens. 2025. doi:10.3390/pathogens14020132

BibTeX
@article{Jang2025,
  author = {Jang, Yumi and Bunz, Fred},
  title = {Dynamic Modulation of IRE1α-XBP1 Signaling by Adenovirus},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14020132}
}
Start for free →